BioVaxys Co-Founder and Chief Medical Officer David Berd, MD, to Present at World Vaccine & Immunotherapy Congress West Coast 2021
November 17, 2021
VANCOUVER, BC, November 17th, 2021 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB,OTCQB:BVAXF) (“BioVaxys” or “Company”), a clinical-stage immunotherapy company, announced today that Company Co-Founder and Chief Medical Officer David Berd, MD, will [...]